Abstract
Purpose
To evaluate the feasibility, risks, and techniques of percutaneous removal of permanent TrapEase and Simon Nitinol IVC filters.
Materials and Methods
Between August 2011 and August 2015, 12 patients (5 women, 7 men; age range, 26–75 years) underwent an attempt at percutaneous removal of permanent TrapEase (10) and Simon Nitinol (2) IVC filters due to a history of IVC filter complications or need for lifelong anticoagulation due to the filter. Medical records were reviewed for filter dwell time, presence of iliocaval deep venous thrombosis, procedural technique, and complications.
Results
Filter dwell times ranged from 7 days to 15 years (mean 5.1 years). Successful removal of permanent IVC filters was possible in 11 of 12 patients (91.6 %). In 1 patient, a chronically thrombosed IVC filter could not be removed despite laser sheath assistance, but was successfully recanalized with the PowerWire RF guidewire. In the failed retrieval attempt, a stent was placed through the chronically thrombosed IVC filter with restoration of in-line flow. One major complication of large venous groin hematoma was encountered.
Conclusions
In carefully selected patients, percutaneous removal of permanent IVC filters can be performed safely despite prolonged filter dwell times. Extraction of chronically embedded permanent IVC filters may be facilitated by jugular and femoral approaches, often with laser sheath assistance. Chronic filter thrombosis and caval scarring may increase the risk of retrieval failure.
Similar content being viewed by others
References
Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, ISTH Steering Committee for World Thrombosis Day, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014;34(11):2363–71.
Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med. 1998;338(7):409–15.
Van Ha TG. Complications of inferior vena caval filters. Semin Intervent Radiol. 2006;23(2):150–5.
Removing Retrievable Inferior Vena Cava Filters: Initial Communication. US FDA; 2010 [19th April 2015]; Available from: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm221676.htm. Accessed 29 Sept 2015.
Yallampalli S, Irani Z, Kalva SP. Endovascular removal of a permanent “TrapEase” inferior vena cava filter. Vasc Endovascular Surg. 2013;47(5):379–82.
Nutting C, Coldwell D. Use of a TrapEase device as a temporary caval filter. J Vasc Interv Radiol. 2001;12(8):991–3.
Kumar BC, Chakraverty S, Zealley I. Removal of a permanent IVC filter. Cardiovasc Intervent Radiol. 2006;29(1):124–5.
Richard HM 3rd. Removal of a TrapEase inferior vena cava filter for chronic abdominal pain 2 years after implantation. J Vasc Interv Radiol. 2013;24(9):1419–21.
Naidu SG, Stone WM, Sweeney JP, Money SR. Endovascular retrieval of a TrapEase permanent inferior vena cava filter from the aorta. J Vasc Surg. 2012;55(1):237–9.
Morishita H, Yamagami T, Matsumoto T, Takeuchi Y, Sato O, Nishimura T. Endovascular repair of a perforation of the vena caval wall caused by the retrieval of a Gunther Tulip filter after long-term implantation. Cardiovasc Intervent Radiol. 2011;34(Suppl 2):S321–3.
Chung J, Owen RJ. Using inferior vena cava filters to prevent pulmonary embolism. Can Fam Physician. 2008;54(1):49–55.
Anderson RC, Bussey HI. Retrievable and permanent inferior vena cava filters: selected considerations. Pharmacotherapy. 2006;26(11):1595–600.
Kalva SP, Wicky S, Waltman AC, Athanasoulis CA. TrapEase vena cava filter: experience in 751 patients. J Endovasc Ther. 2006;13(3):365–72.
Poletti PA, Becker CD, Prina L, Ruijs P, Bounameaux H, Didier D, et al. Long-term results of the Simon nitinol inferior vena cava filter. Eur Radiol. 1998;8(2):289–94.
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e419S–94S.
Ray CE Jr, Prochazka A. The need for anticoagulation following inferior vena cava filter placement: systematic review. Cardiovasc Intervent Radiol. 2008;31(2):316–24.
Corriere MA, Sauve KJ, Ayerdi J, Craven BL, Stafford JM, Geary RL, et al. Vena cava filters and inferior vena cava thrombosis. J Vasc Surg. 2007;45(4):789–94.
Durack JC, Westphalen AC, Kekulawela S, Bhanu SB, Avrin DE, Gordon RL, et al. Perforation of the IVC: rule rather than exception after longer indwelling times for the Günther Tulip and Celect retrievable filters. Cardiovasc Intervent Radiol. 2012;35(2):299–308.
Kuo WT, Cupp JS, Louie JD, Kothary N, Hofmann LV, Sze DY, et al. Complex retrieval of embedded IVC filters: alternative techniques and histologic tissue analysis. Cardiovasc Intervent Radiol. 2012;35(3):588–97.
Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV. Excimer laser-assisted removal of embedded inferior vena cava filters: a single-center prospective study. Circ Cardiovasc Interv. 2013;6(5):560–6.
Mousa AY, AbuHalimah S, Yacoub M, Sheikh I, AbuRahma AF. Tips and tricks for retrieval of permanent TRAPEASE® filters for inferior vena cava. Vascular. 2014. doi:10.1177/1708538114560456.
Neglen P, Oglesbee M, Olivier J, Raju S. Stenting of chronically obstructed inferior vena cava filters. J Vasc Surg. 2011;54(1):153–61.
Funding
Dr Michael Streiff has received research funding from Daiichi-Sankyo, Janssen, and Portola and consulted for BiO2Medical, Boehringer-Ingelheim, Daiichi-Sankyo, Eisai, and Janssen HealthCare. Dr Mark L Lessne has received research funding from Merit Medical, consulted for Apriomed, and is an investigator on Cook Medical IVC filter trial.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Anobel Tamrazi, Vibhor Wadhwa, Brian Holly, Nikhil Bhagat, and Jonathan K Marx have no conflicts of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Tamrazi, A., Wadhwa, V., Holly, B. et al. Percutaneous Retrieval of Permanent Inferior Vena Cava Filters. Cardiovasc Intervent Radiol 39, 538–546 (2016). https://doi.org/10.1007/s00270-015-1214-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-015-1214-0